BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15555581)

  • 1. Multifaceted role of galectin-3 on human glioblastoma cell motility.
    Debray C; Vereecken P; Belot N; Teillard P; Brion JP; Pandolfo M; Pochet R
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1393-8. PubMed ID: 15555581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern.
    Camby I; Decaestecker C; Lefranc F; Kaltner H; Gabius HJ; Kiss R
    Biochem Biophys Res Commun; 2005 Sep; 335(1):27-35. PubMed ID: 16051185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells.
    Servotte S; Camby I; Debeir O; Deroanne C; Lambert CA; Lapière CM; Kiss R; Nusgens B; Decaestecker C
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):575-84. PubMed ID: 17083472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
    Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
    J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
    Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
    Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
    O'Driscoll L; Linehan R; Liang YH; Joyce H; Oglesby I; Clynes M
    Anticancer Res; 2002; 22(6A):3117-25. PubMed ID: 12530054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
    Mazurek N; Sun YJ; Price JE; Ramdas L; Schober W; Nangia-Makker P; Byrd JC; Raz A; Bresalier RS
    Cancer Res; 2005 Dec; 65(23):10767-75. PubMed ID: 16322222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration.
    Strik HM; Schmidt K; Lingor P; Tönges L; Kugler W; Nitsche M; Rabinovich GA; Bähr M
    Oncol Rep; 2007 Aug; 18(2):483-8. PubMed ID: 17611674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
    van den Brûle FA; Buicu C; Sobel ME; Liu FT; Castronovo V
    Neoplasma; 1995; 42(5):215-9. PubMed ID: 8552198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases.
    Camby I; Belot N; Lefranc F; Sadeghi N; de Launoit Y; Kaltner H; Musette S; Darro F; Danguy A; Salmon I; Gabius HJ; Kiss R
    J Neuropathol Exp Neurol; 2002 Jul; 61(7):585-96. PubMed ID: 12125737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
    Song S; Byrd JC; Mazurek N; Liu K; Koo JS; Bresalier RS
    Gastroenterology; 2005 Nov; 129(5):1581-91. PubMed ID: 16285957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
    Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
    J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.
    Lee LH; Moh MC; Zhang T; Shen S
    J Cell Biochem; 2009 Aug; 107(6):1129-38. PubMed ID: 19507233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
    Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
    Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells.
    Guo H; Gu F; Li W; Zhang B; Niu R; Fu L; Zhang N; Ma Y
    J Neurochem; 2009 Apr; 109(1):203-13. PubMed ID: 19187446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
    Demers M; Biron-Pain K; Hébert J; Lamarre A; Magnaldo T; St-Pierre Y
    Cancer Res; 2007 Mar; 67(6):2824-9. PubMed ID: 17363605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.
    Wang L; Tabu K; Kimura T; Tsuda M; Linghu H; Tanino M; Kaneko S; Nishihara H; Tanaka S
    Biochem Biophys Res Commun; 2007 Nov; 362(4):976-81. PubMed ID: 17825249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.
    Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R
    J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.